Peter Söderkvist

Platform Scientific Director, Linköping University

Key Publications
Methylome analysis for prediction of long and short-term survival in glioblastoma patients from the Nordic trial
2022
Autosomal recessive congenital hereditary corneal dystrophy associated with a novel SLC4A11 mutation in two consanguineous Tunisian families
British Journal of Ophthalmology, 2022
Polymorphisms in CARD8 and NLRP3 are associated with extrapulmonary TB and poor clinical outcome in active TB in Ethiopia
Scientific Reports, 2019

My research interest is focused to the the underlying mechansims in carcinogenesis, identification of susceptibility genes for tumors in general and more recently for brain and endocrine (e.g pheochromocytoma) tumors. How genes and genetic variants contribute to cancer and can be used for targeted therapies represents a major activity. Our research is performed mainly on patient cohorts and novel susceptibility genes and genetic variants are investigated for functionality in cell culture models. A major aim is the development of biomarkers and diagnostic tools for individualized treatment and clinical use. The use of molecular genetic technologies has also expanded to other diseases and studies on genetic variation in inflammatory diseases and in an international collaboration on familial eye disorders to identify contributing susceptibility genes and genetic variants.

Group Members:

Malgorzata Lysiak, PhD
Åsa Schippert, BMA
Mouna Tababi, PhD
Hugo Rossitti, MD
Malgorzata Trybula, Pharm Sc
Annika Malmström, MD, PhD
Oliver Gimm, MD, PhD

Last updated: 2023-06-13

Content Responsible: Hampus Pehrsson Ternström(hampus.persson@scilifelab.uu.se)

Help Us Improve!
We want to better match our services with your needs—take our short survey and help shape SciLifeLab’s digital future. You can also join our user panel for occasional feedback opportunities and early access to new tools.
Help Us Improve!
We want to better match our services with your needs—take our short survey and help shape SciLifeLab’s digital future. You can also join our user panel for occasional feedback opportunities and early access to new tools.